Malgorzata Kaluza
Family Medicine · St Augustine, FLNPI 1548282684
Payments from drug & device makers
Across 312 payments — averaging $24.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$1K
- Lilly USA, LLC$1K
- Novo Nordisk$743
- Boehringer Ingelheim$645
- Amgen$560
- plus $2K from 23 others
What the payments were for
- Food & beverage$7,611100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 30 | $1,173 |
| AbbVie(2 entities) | 48 | $1,140 |
| Lilly USA, LLC | 42 | $1,066 |
| Novo Nordisk | 27 | $743 |
| Boehringer Ingelheim | 28 | $645 |
| Amgen(2 entities) | 17 | $560 |
| Amarin Pharma, Inc. | 46 | $541 |
| Optinose US, Inc. | 5 | $215 |
| GSK | 11 | $169 |
| Silk Road Medical, Inc. | 1 | $165 |
| Kowa Pharmaceuticals America, Inc. | 9 | $151 |
| Pfizer | 8 | $150 |
| Novartis | 8 | $148 |
| Biohaven Pharmaceuticals, Inc. | 2 | $134 |
| Stryker | 1 | $115 |
| Merck | 5 | $85 |
| Bausch Health US, LLC | 3 | $58 |
| Eisai Inc. | 3 | $48 |
| Johnson & Johnson | 2 | $43 |
| Daiichi Sankyo Inc. | 2 | $43 |
| Astellas Pharma US Inc | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Jazz Pharmaceuticals Inc. | 2 | $28 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Vivus LLC | 2 | $25 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$344
- MOUNJARO$221
- ENROUTE Transcarotid Stent$165
- ENHANCE Transcarotid Peripheral Access Kit$165
- ENROUTE .014 Guidewire$165
- ENROUTE Transcarotid Neuroprotection System$165
- BREZTRI$127
- Ozempic$125
- AIRSUPRA$122
- RYBELSUS$122
- Otezla$122
- Repatha$121
- Xhance$121
- QULIPTA$116
- UBRELVY$116
- MAKO$115
- BREZTRI AEROSPHERE$114
- NURTEC ODT$111
- Creon$109
- JARDIANCE$100
How this compares
$7,619 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 29 | $37,768 |
| JardianceEmpagliflozin | 19 | $28,391 |
| MounjaroTirzepatide | 25 | $26,875 |
| EntrestoSacubitril/Valsartan | 25 | $22,218 |
| OzempicSemaglutide | 19 | $18,254 |
| TradjentaLinagliptin | 15 | $13,721 |
| XareltoRivaroxaban | 12 | $12,394 |
| MyrbetriqMirabegron | 11 | $9,322 |
| Wixela InhubFluticasone Propion/Salmeterol | 33 | $2,411 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 56 | $1,996 |
| SynthroidLevothyroxine Sodium | 28 | $1,651 |
| Levothyroxine Sodium | 150 | $1,427 |
| Atorvastatin Calcium | 128 | $1,311 |
| Duloxetine Hcl | 38 | $956 |
| Bupropion XlBupropion Hcl | 17 | $791 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $645 | $42,11234 claims |
| PfizerEliquis | $150 | $37,76829 claims |
| Lilly USA, LLCMounjaro | $1,066 | $26,87525 claims |
| NovartisEntresto | $148 | $22,21825 claims |
| Novo NordiskOzempic | $743 | $18,25419 claims |
| Johnson & JohnsonXarelto | $43 | $12,39412 claims |
| Astellas Pharma US IncMyrbetriq | $40 | $9,32211 claims |
| AbbVieSynthroid | $1,140 | $1,65128 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.
Other family medicine in St Augustine
- Hugh ColemanDaytona Beach$115.5M
- Alexander WhiteDaytona Beach$69.7M
- Ronald SurowitzJupiter$38.3M
- Bruce RankinDeland$36.7M
- Keila HooverMiami$33.7M
- John NardandreaOcala$30.8M
- Jorge CasoMiami$22.6M
- Sharrell CooperPalm Coast$16.9M
- Christopher GallowayMelbourne$15.6M
- Dario AltamiranoHialeah$15.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.